Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|April 22, 1985
Platelet regeneration time after aspirin ingestion and platelet survival time after labelling with 51chromium or 111indium oxine--a comparative studyA Boneu, P Sié, R Bugat, et al.
Genes, Chromosomes & Cancer|December 18, 2001
Novel germline RET mutation segregating with papillary thyroid carcinomasJ M Rey, J P Brouillet, J Fonteneau-Allaire, et al.
Cancer|February 15, 1996
Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring systemA Suc, J Lumbroso, H Rubie, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|January 1, 1992
[Multiple localization and lymphatic involvement of papillary micro-carcinoma of the thyroid. Results of total thyroidectomy with bilateral lymph node excision. Apropos of 38 patients]J M David, C Ruaux, J M Bachaud, et al.
La Nouvelle Presse Medicale|February 14, 1976
[The half-life of iodine 131-labelled fibrinogen in cancer patients. Effects of heparin]A Boneu, J P Armand, A Blasco, et al.
Journal of the National Cancer Institute|April 19, 1995
Prediction of carboplatin clearance from standard morphological and biological patient characteristicsE Chatelut, P Canal, V Brunner, et al.
Bulletin Du Cancer|November 1, 1995
[Prediction of carboplatin clearance from morphological and biological patient characteristics]E Chatelut, A Dezeuze, M Lavit, et al.
Journal De Radiologie, D'Electrologie, Et De Medecine Nucleaire|November 1, 1977
[Thyroid carcinomas. Critical study about 138 observations. Therapeutic deductions (author's transl)]H Lucot, A Blasco, A Boneu, et al.
Bulletin Du Cancer|March 1, 1994
[Concomitant association of radiotherapy and chemotherapy (CDDP 4-6 mg/m2/daily in continuous i.v. administration) in locally advanced ORL tumors]J M Bachaud, N Albin, C Gay, et al.
Hormone Research|January 1, 1997
Multiple endocrine neoplasia type 2: management of patients and subjects at risk. French Study Group on Calcitonin-Secreting Tumors (GETC)B Conte-Devolx, I Schuffenecker, P Niccoli, et al.
Pageof 3